# NEUROCRINE BIOSCIENCES INC (NBIX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from NEUROCRINE BIOSCIENCES INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NBIX/mda/fy2025/): filed 2026-02-11; accession 0000914475-26-000007 (https://www.sec.gov/Archives/edgar/data/914475/000091447526000007/nbix-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NBIX/mda/fy2024/): filed 2025-02-10; accession 0000914475-25-000037 (https://www.sec.gov/Archives/edgar/data/914475/000091447525000037/nbix-20241231.htm)
- [FY 2023 MD&A](/company/NBIX/mda/fy2023/): filed 2024-02-09; accession 0000914475-24-000054 (https://www.sec.gov/Archives/edgar/data/914475/000091447524000054/nbix-20231231.htm)
- [FY 2022 MD&A](/company/NBIX/mda/fy2022/): filed 2023-02-09; accession 0000914475-23-000011 (https://www.sec.gov/Archives/edgar/data/914475/000091447523000011/nbix-20221231.htm)
- [FY 2021 MD&A](/company/NBIX/mda/fy2021/): filed 2022-02-11; accession 0000914475-22-000013 (https://www.sec.gov/Archives/edgar/data/914475/000091447522000013/nbix-20211231.htm)

Back to /company/NBIX/